Related content

Efficacy and safety of prolonged-release OROS methylphenidate in adults with attention deficit/hyperactivity disorder: A 13-week, randomized, double-blind, placebo-controlled, fixed-dose study

By Casas Miguel  

World Journal of Biological Psychiatry, Vol. 14, Iss. 4, 2013-05 ,pp. : 268-281

Informa Healthcare

Access to resources Recommend Favorite

Methylphenidate improves response inhibition in adults with attention-deficit/hyperactivity disorder

By Aron A.R.   Dowson J.H.   Sahakian B.J.   Robbins T.W.  

Biological Psychiatry, Vol. 54, Iss. 12, 2003-12 ,pp. : 1465-1468

Elsevier

Access to resources Recommend Favorite

Do the beneficial effects of extended methylphenidate treatment in boys with attention-deficit hyperactivity disorder dissipate rapidly during placebo treatment?

By  

Nordic Journal of Psychiatry, Vol. 53, Iss. 1, 1999-03 ,pp. : 55-60

Informa Healthcare

Access to resources Recommend Favorite

Bupropion SR vs. Methylphenidate vs. Placebo for Attention Deficit Hyperactivity Disorder in Adults

By Kuperman S.  

Annals of Clinical Psychiatry (after Jan 1, 2004), Vol. 13, Iss. 3, 2001-09 ,pp. : 129-134

Springer Publishing Company

Access to resources Recommend Favorite

Acetyl-L-Carnitine as an Adjunctive Therapy in the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: A Placebo-Controlled Trial

By Abbasi Seyed-Hesameddin  

Child Psychiatry and Human Development, Vol. 42, Iss. 3, 2011-06 ,pp. : 367-375

Springer Publishing Company

Access to resources Recommend Favorite